[{"NetIncomeLossConverted_1_Q1_USD":-61000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":486700000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":22000000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.12,"CommonStockSharesOutstanding_0_Q1_shares":472968567.0,"StockholdersEquity_0_Q1_USD":8007000000.0,"RevenuesConverted_1_Q1_USD":1242000000.0,"Assets_0_Q1_USD":16988000000.0,"CommonStockSharesConverted_0_Q1_shares":472968567.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":486700000.0,"EarningsPerShareBasic_1_Q1_USD":-0.12,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210507"}]